$SSSS
SURO CAPITAL CORP. Stock $ssss

$ssss Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224030665 Filed on August 08, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	-$3.208M	-$3.656M
YoY Change	20.22%	-3.93%
Cost Of Revenue	$1.153M	$1.214M
YoY Change	-5.45%	0.0%
Gross Profit	-$264.8K	-$186.9K
YoY Change	-205.9%	-218.34%
Gross Profit Margin
Selling, General & Admin	$2.603M	$3.006M
YoY Change	1.69%	-8.55%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$4.097M	$4.683M
YoY Change	-0.91%	-9.55%
Operating Profit	-$4.361M	-$4.870M
YoY Change	12.28%	-2.98%
Interest Expense	-$2.244M	-$6.996M
YoY Change	-284.68%	-676.11%
% of Operating Profit
Other Income/Expense, Net	$339.9K	$462.8K
YoY Change	-4.66%	-31.58%
Pretax Income	-$5.452M	-$10.65M
YoY Change	-121.64%	-31.81%
Income Tax		$52.79K
% Of Pretax Income
Net Earnings	-$5.452M	-$10.65M
YoY Change	-121.64%	-31.81%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.23	-$0.45
Diluted Earnings Per Share	-$0.23	-$0.45
COMMON SHARES
Basic Shares Outstanding	23.38M shares	23.35M shares
Diluted Shares Outstanding	23.38M shares	23.41M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$32.74M	$54.38M
YoY Change	-55.46%	121.57%
Cash & Equivalents	$32.74M	$54.38M
Short-Term Investments
Other Short-Term Assets	$971.4K	$282.6K
YoY Change	38.77%	-41.76%
Inventory
Prepaid Expenses
Receivables	$88.95K	$83.84K
Other Receivables	$188.7K	$71.05K
Total Short-Term Assets	$33.99M	$54.82M
YoY Change	-54.44%	109.32%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$199.3M	$182.9M
YoY Change	-6.78%	-22.56%
Other Assets	$493.0K	$561.1K
YoY Change	-17.84%	-4.97%
Total Long-Term Assets	$199.8M	$183.5M
YoY Change	-6.8%	-22.51%
TOTAL ASSETS
Total Short-Term Assets	$33.99M	$54.82M
Total Long-Term Assets	$199.8M	$183.5M
Total Assets	$233.8M	$238.3M
YoY Change	-19.1%	-9.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.985M	$2.003M
YoY Change	-6.7%	-20.26%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.030M	$2.047M
YoY Change	-10.88%	-24.16%
LONG-TERM LIABILITIES
Long-Term Debt	$73.31M	$73.92M
YoY Change	-0.52%	0.49%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$73.31M	$73.92M
YoY Change	-0.52%	0.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.030M	$2.047M
Total Long-Term Liabilities	$73.31M	$73.92M
Total Liabilities	$76.34M	$75.97M
YoY Change	-0.86%	-0.38%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$233.8K	$233.8K
YoY Change	-7.26%	-7.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$157.4M	$162.3M
YoY Change
Total Liabilities & Shareholders Equity	$233.8M	$238.3M
YoY Change	-19.11%	-9.38%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$5.452M	-$10.65M
YoY Change	-121.64%	-31.81%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$20.89M	$12.97M
YoY Change	-142.04%	-228.74%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-750.3K	-9.400M
YoY Change	7.18%	-30.37%
NET CHANGE
Cash From Operating Activities	-20.89M	12.97M
Cash From Investing Activities
Cash From Financing Activities	-750.3K	-9.400M
Net Change In Cash	-21.64M	3.565M
YoY Change	-144.17%	-115.13%
FREE CASH FLOW
Cash From Operating Activities	-$20.89M	$12.97M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	SSSS	Directors Fees DirectorsFees	161661	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	73745207	usd
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	814-00852
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-4443543
	dei	Entity Address Address Line1 EntityAddressAddressLine1	640 Fifth Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	12th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10019
	dei	City Area Code CityAreaCode	(212)
	dei	Local Phone Number LocalPhoneNumber	931-6331
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23378002	shares
CY2024Q2	SSSS	Escrow Proceeds Receivable EscrowProceedsReceivable	71044	usd
CY2024Q2	SSSS	Interest And Dividends Receivable InterestAndDividendsReceivable	83844	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	282555	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	2002539	usd
CY2024Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	44700	usd
CY2024Q2	us-gaap	Notes Payable NotesPayable	73923741	usd
CY2024Q2	us-gaap	Liabilities Liabilities	75970980	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	233780	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	240145859	usd
CY2024Q2	SSSS	Accumulated Net Investment Loss AccumulatedNetInvestmentLoss	-11182638	usd
CY2024Q2	SSSS	Accumulated Net Realized Gain On Investments Net Of Distributions AccumulatedNetRealizedGainOnInvestmentsNetOfDistributions	-12802458	usd
CY2024Q2	SSSS	Accumulated Net Unrealized Depreciation Appreciation Of Investments AccumulatedNetUnrealizedDepreciationAppreciationOfInvestments	-54082352	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	162312191	usd
CY2024Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	6.94
	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	(1) 98% of its ordinary income (taking into account certain deferrals and elections) for each calendar year, (2) 98.2% of its capital gain net income (adjusted for certain ordinary losses) for the 1-year period ending October 31 of each such calendar year and (3) any ordinary income and net capital gains for preceding years, but not distributed during such years and on which the Company paid no U.S. federal income tax. The Company will not be subject to this excise tax on any amount on which the Company incurred U.S. federal corporate income tax (such as the tax imposed on a RIC’s retained net capital gains).
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.04	pure
CY2024Q2	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	1076259	usd
CY2023Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	1254793	usd
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q2	SSSS	Investments In U.S.Treasury Bills InvestmentsInU.s.TreasuryBills		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2026-12-30
	SSSS	Purchases Of Us Treasury Bills Investments PurchasesOfUSTreasuryBillsInvestments		usd
	SSSS	Increase Decrease In Proceeds Receivable IncreaseDecreaseInProceedsReceivable		usd
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2026-12-30
CY2024Q2	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Registrant Name EntityRegistrantName	SuRo Capital Corp.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.01
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	184081249	usd
CY2023Q4	SSSS	Investments In U.S.Treasury Bills InvestmentsInU.s.TreasuryBills	63810855	usd
CY2023Q4	us-gaap	Investments Investments	247892104	usd
CY2023Q4	us-gaap	Cash Cash	28178352	usd
CY2023Q4	SSSS	Escrow Proceeds Receivable EscrowProceedsReceivable	309293	usd
CY2023Q4	SSSS	Interest And Dividends Receivable InterestAndDividendsReceivable	132607	usd
CY2024Q2	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	561075	usd
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	594726	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	494602	usd
CY2024Q2	us-gaap	Assets Assets	238283171	usd
CY2023Q4	us-gaap	Assets Assets	277601684	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	346308	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	152523	usd
CY2023Q4	us-gaap	Liabilities Liabilities	74244038	usd
CY2024Q2	us-gaap	Assets Net AssetsNet	162312191	usd
CY2023Q4	us-gaap	Assets Net AssetsNet	203357646	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23378002	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23378002	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25445805	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25445805	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	254458	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	248454107	usd
CY2023Q4	SSSS	Accumulated Net Investment Loss AccumulatedNetInvestmentLoss	-4304111	usd
CY2023Q4	SSSS	Accumulated Net Realized Gain On Investments Net Of Distributions AccumulatedNetRealizedGainOnInvestmentsNetOfDistributions	-12348772	usd
CY2023Q4	SSSS	Accumulated Net Unrealized Depreciation Appreciation Of Investments AccumulatedNetUnrealizedDepreciationAppreciationOfInvestments	-28698036	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	203357646	usd
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	7.99
CY2024Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0600	pure
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2026-12-30
CY2024Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0600	pure
CY2024Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0653	pure
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	75000000	usd
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0600	pure
CY2023Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0653	pure
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	75000000	usd
CY2024Q2	us-gaap	Investment Income Net InvestmentIncomeNet	1027353	usd
CY2023Q2	us-gaap	Investment Income Net InvestmentIncomeNet	1372218	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	2555444	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	2671300	usd
CY2024Q2	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	2198509	usd
CY2023Q2	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	2117872	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	4383827	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	4254626	usd
CY2024Q2	SSSS	Directors Fees DirectorsFees	167825	usd
	SSSS	Directors Fees DirectorsFees	338938	usd
	SSSS	Directors Fees DirectorsFees	322226	usd
CY2024Q2	us-gaap	Professional Fees ProfessionalFees	586825	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	916579	usd
	us-gaap	Professional Fees ProfessionalFees	1315384	usd
	us-gaap	Professional Fees ProfessionalFees	1907413	usd
CY2024Q2	us-gaap	Interest Expense Operating InterestExpenseOperating	1214267	usd
CY2023Q2	us-gaap	Interest Expense Operating InterestExpenseOperating	1214267	usd
	us-gaap	Interest Expense Operating InterestExpenseOperating	2428534	usd
	us-gaap	Interest Expense Operating InterestExpenseOperating	2427553	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	52794	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	90826	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	54894	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	620606	usd
CY2024Q2	us-gaap	Other Expenses OtherExpenses	462758	usd
CY2023Q2	us-gaap	Other Expenses OtherExpenses	676353	usd
	us-gaap	Other Expenses OtherExpenses	912394	usd
	us-gaap	Other Expenses OtherExpenses	1165981	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	4682978	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	5177558	usd
	us-gaap	Operating Expenses OperatingExpenses	9433971	usd
	us-gaap	Operating Expenses OperatingExpenses	10698405	usd
CY2024Q2	us-gaap	Net Investment Income NetInvestmentIncome	-3655625	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	-3805340	usd
	us-gaap	Net Investment Income NetInvestmentIncome	-6878527	usd
	us-gaap	Net Investment Income NetInvestmentIncome	-8027105	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-29612	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-13270199	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-453686	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-13080856	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-6965946	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1455515	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-25384316	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	10104446	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-10651183	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-15620024	usd
	us-gaap	Net Income Loss NetIncomeLoss	-32716529	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11003515	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.34
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23410235	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25952447	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24401863	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27158786	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23410235	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25952447	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24401863	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27158786	shares
CY2023Q4	us-gaap	Assets Net AssetsNet	203357646	usd
CY2022Q4	us-gaap	Assets Net AssetsNet	210020702	usd
CY2024Q1	us-gaap	Net Investment Income NetInvestmentIncome	-3222902	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	-4221765	usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-424074	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	189343	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-18418370	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	8648931	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-22065346	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4616509	usd
CY2024Q1	SSSS	Stock Issued During Period Values Share Based Compensation Gross StockIssuedDuringPeriodValuesShareBasedCompensationGross	428835	usd
CY2023Q1	SSSS	Stock Issued During Period Values Share Based Compensation Gross StockIssuedDuringPeriodValuesShareBasedCompensationGross	405858	usd
CY2024Q1	SSSS	Investment Company Capital Share Transactions InvestmentCompanyCapitalShareTransactions	428835	usd
CY2023Q1	SSSS	Investment Company Capital Share Transactions InvestmentCompanyCapitalShareTransactions	405858	usd
CY2024Q1	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-21636511	usd
CY2023Q1	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	5022367	usd
CY2024Q1	us-gaap	Assets Net AssetsNet	181721135	usd
CY2023Q1	us-gaap	Assets Net AssetsNet	215043069	usd
CY2024Q2	us-gaap	Net Investment Income NetInvestmentIncome	-3655625	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	-3805340	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-29612	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-13270199	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-6965946	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1455515	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-10651183	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-15620024	usd
CY2024Q2	SSSS	Stock Issued During Period Values Share Based Compensation Gross StockIssuedDuringPeriodValuesShareBasedCompensationGross	642239	usd
CY2023Q2	SSSS	Stock Issued During Period Values Share Based Compensation Gross StockIssuedDuringPeriodValuesShareBasedCompensationGross	769679	usd
CY2024Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	9400000	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	13500000	usd
CY2024Q2	SSSS	Investment Company Capital Share Transactions InvestmentCompanyCapitalShareTransactions	-8757761	usd
CY2023Q2	SSSS	Investment Company Capital Share Transactions InvestmentCompanyCapitalShareTransactions	-12730321	usd
CY2024Q2	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-19408944	usd
CY2023Q2	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-28350345	usd
CY2024Q2	us-gaap	Assets Net AssetsNet	162312191	usd
CY2023Q2	us-gaap	Assets Net AssetsNet	186692724	usd
CY2023Q4	us-gaap	Shares Outstanding SharesOutstanding	25445805	shares
CY2022Q4	us-gaap	Shares Outstanding SharesOutstanding	28429499	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	67803	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	30859	shares
	SSSS	Stock Repurchased For Capital Share Activity StockRepurchasedForCapitalShareActivity	-2000000	shares
	SSSS	Stock Repurchased For Capital Share Activity StockRepurchasedForCapitalShareActivity	-3000000	shares
CY2024Q2	us-gaap	Shares Outstanding SharesOutstanding	23378002	shares
CY2023Q2	us-gaap	Shares Outstanding SharesOutstanding	25398640	shares
	us-gaap	Net Income Loss NetIncomeLoss	-32716529	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11003515	usd
	SSSS	Realized Investment Gain Losses RealizedInvestmentGainLosses	-453686	usd
	SSSS	Realized Investment Gain Losses RealizedInvestmentGainLosses	-13080856	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-25384316	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	10104446	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	212187	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	142894	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1071074	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1175537	usd
	SSSS	Adjustments To Escrow Proceeds Receivable AdjustmentsToEscrowProceedsReceivable	-139925	usd
	SSSS	Adjustments To Escrow Proceeds Receivable AdjustmentsToEscrowProceedsReceivable	211918	usd
	SSSS	Accrued Interest On Us Treasury Bills AccruedInterestOnUSTreasuryBills	-18150	usd
	SSSS	Accrued Interest On Us Treasury Bills AccruedInterestOnUSTreasuryBills	385692	usd
	SSSS	Purchases Of Portfolio Investments PurchasesOfPortfolioInvestments	35073044	usd
	SSSS	Purchases Of Portfolio Investments PurchasesOfPortfolioInvestments	12514713	usd
	SSSS	Purchases Of Us Treasury Bills Investments PurchasesOfUSTreasuryBillsInvestments	141793045	usd
	SSSS	Proceeds From Sales Or Maturity Of Investments Portfolio Investments ProceedsFromSalesOrMaturityOfInvestmentsPortfolioInvestments	10551335	usd
	SSSS	Proceeds From Sales Or Maturity Of Investments Portfolio Investments ProceedsFromSalesOrMaturityOfInvestmentsPortfolioInvestments	6257861	usd
	SSSS	Proceeds From Sales Or Maturity Of Investments Us Treasury Bills ProceedsFromSalesOrMaturityOfInvestmentsUSTreasuryBills	63792704	usd
	SSSS	Proceeds From Sales Or Maturity Of Investments Us Treasury Bills ProceedsFromSalesOrMaturityOfInvestmentsUSTreasuryBills	151313976	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-212047	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-241835	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-48763	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-19218	usd
	SSSS	Increase Decrease In Proceeds Receivable IncreaseDecreaseInProceedsReceivable	664470	usd
	SSSS	Increase Decrease In Escrow Proceeds Receivable IncreaseDecreaseInEscrowProceedsReceivable	-238249	usd
	SSSS	Increase Decrease In Escrow Proceeds Receivable IncreaseDecreaseInEscrowProceedsReceivable	-252367	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1656231	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1802373	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	35709244	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1967046	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	9400000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	13500000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	107823	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	107823	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9507823	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13607823	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	26201421	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-15574869	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	28178352	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	40117598	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	54379773	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24542729	usd
	us-gaap	Interest Paid Net InterestPaidNet	2250000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2250000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	54894	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	530556	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80B_eus-gaap--NatureOfOperations_zqrYWvied5H8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1—<span id="xdx_824_z9J8jLknJ1rg">NATURE OF OPERATIONS</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SuRo Capital Corp. (“we”, “us”, “our”, the “Company” or “SuRo Capital”), formerly known as Sutter Rock Capital Corp. and as GSV Capital Corp. and formed in September 2010 as a Maryland corporation, is an internally managed, non-diversified closed-end management investment company. The Company has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”), and has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s date of inception was January 6, 2011, which is the date it commenced development stage activities. The Company’s common stock is currently listed on the Nasdaq Global Select Market under the symbol “SSSS” (formerly “GSVC”). Prior to November 24, 2021, the Company’s common stock traded on the Nasdaq Capital Market under the same symbol (“SSSS”). The Company began its investment operations during the second quarter of 2011.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below displays the Company’s subsidiaries as of June 30, 2024, which, other than GSV Capital Lending, LLC (“GCL”) and SuRo Capital Sports, LLC, are collectively referred to as the “Taxable Subsidiaries.” The Taxable Subsidiaries were formed to hold certain portfolio investments. The Taxable Subsidiaries, including their associated portfolio investments, are consolidated with the Company for accounting purposes, but have elected to be treated as separate entities for U.S. federal income tax purposes. GCL was formed to originate portfolio loan investments within the state of California and is consolidated with the Company for accounting purposes. Refer to “Note 2—Significant Accounting Policies—<i>Basis of Consolidation</i>” below for further detail.</span></p> <p id="xdx_894_ecustom--ScheduleOfSubsidiariesOfCompanyTableTextBlock_zpXLY1Dwyee7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B5_zN3RDafMykX5" style="display: none">SCHEDULE OF COMPANY’S SUBSIDIARIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 56%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subsidiary</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jurisdiction of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Formation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Owned</b></span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GCL</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20240101__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_zaE0DKFhcA5l" title="Jurisdiction of Incorporation">Delaware</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--EntityIncorporationDateOfIncorporation_c20240101__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_zziP59Dawmv6" title="Formation Date">April 13, 2012</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_zLyA1bOInR9l" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Percentage Owned"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SuRo Capital Sports, LLC (“SuRo Sports”)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20240101__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_zvzVmWDk2zSl" title="Jurisdiction of Incorporation">Delaware</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityIncorporationDateOfIncorporation_c20240101__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_z6Kntu5QDSW4" title="Formation Date">March 19, 2021</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_ze24G9xhIuL4" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Percentage Owned"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subsidiaries below are referred to collectively as the “Taxable Subsidiaries”</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GSVC AE Holdings, Inc. (“GAE”)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20240101__20240630__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember_z18xdISdIEXg" title="Jurisdiction of Incorporation">Delaware</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityIncorporationDateOfIncorporation_c20240101__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_z33vNeM1I5B9" title="Formation Date">November 28, 2012</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zudMS4IkW0xc" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Percentage Owned"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GSVC AV Holdings, Inc. (“GAV”)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20240101__20240630__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember_zMQILF1eBaPa" title="Jurisdiction of Incorporation">Delaware</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--EntityIncorporationDateOfIncorporation_c20240101__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_z32HBcg49p17" title="Formation Date">November 28, 2012</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zKce9geC4qG" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Percentage Owned"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GSVC SW Holdings, Inc. (“GSW”)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--EntityIncorporationStateCountryCode_c20240101__20240630__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember_zgNMcJhx9y39" title="Jurisdiction of Incorporation">Delaware</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityIncorporationDateOfIncorporation_c20240101__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_z9g5HwCeD0Ua" title="Formation Date">November 28, 2012</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zHyNs9SoUr53" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Percentage Owned"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GSVC SVDS Holdings, Inc. (“SVDS”)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20240101__20240630__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember_zyWJ1cZrYkkb" title="Jurisdiction of Incorporation">Delaware</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityIncorporationDateOfIncorporation_c20240101__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zVDLwmclRAX2" title="Formation Date">August 13, 2013</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zS2HXoxVSbBk" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Percentage Owned"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td></tr> </table> <p id="xdx_8A7_zAAbjE8G1KB6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s investment objective is to maximize its portfolio’s total return, principally by seeking capital gains on its equity and equity-related investments, and to a lesser extent, income from debt investments. The Company invests principally in the equity securities of what it believes to be rapidly growing venture capital-backed emerging companies. The Company may invest in these portfolio companies through direct offerings of the prospective portfolio companies, transactions on secondary marketplaces for private companies, or negotiations with selling stockholders. In addition, the Company may invest in private credit and in founders equity, founders warrants, forward purchase agreements, and private investment in public equity transactions of special purpose acquisition companies (“SPACs”). The Company may also invest on an opportunistic basis in select publicly traded equity securities or certain non-U.S. companies that otherwise meet its investment criteria, subject to any applicable limitations under the 1940 Act.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SURO CAPITAL CORP. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zMrgS5ns1LY4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_z2q1Q5KAFRod">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of Condensed Consolidated Financial Statements in accordance with GAAP requires the Company’s management to make a number of significant estimates. These include estimates of the fair value of certain assets and liabilities and other estimates that affect the reported amounts of certain assets and liabilities as of the date of the Condensed Consolidated Financial Statements and the reported amounts of certain revenues and expenses during the reporting period. It is likely that changes in these estimates may occur in the near term. The Company’s estimates are inherently subjective in nature and actual results could differ materially from such estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2024Q2	SSSS	Escrow Proceeds Receivable EscrowProceedsReceivable	71044	usd
CY2023Q4	SSSS	Escrow Proceeds Receivable EscrowProceedsReceivable	309293	usd
CY2024Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0600	pure
	SSSS	Description For Deferred Financing Costs DescriptionForDeferredFinancingCosts	The Company records fees and expenses incurred in connection with its 6.00% Notes due 2026 as deferred debt issuance costs. Such costs are reflected in the carrying value of the 6.00% Notes due 2026, and not the Company’s deferred financing costs.
CY2024Q2	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	561075	usd
CY2023Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	594726	usd
CY2024Q2	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	1076259	usd
CY2023Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	1254793	usd
CY2024Q2	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	561075	usd
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	594726	usd
CY2024Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1637334	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1849519	usd
CY2024Q2	us-gaap	Escrow Deposit EscrowDeposit	0	usd
CY2023Q4	us-gaap	Escrow Deposit EscrowDeposit	0	usd
CY2024Q2	SSSS	Number Of Positions NumberOfPositions	65
CY2024Q2	SSSS	Number Of Portfolio Companies NumberOfPortfolioCompanies	39
CY2023Q4	SSSS	Number Of Positions NumberOfPositions	63
CY2023Q4	SSSS	Number Of Portfolio Companies NumberOfPortfolioCompanies	38
CY2024Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	182904880	usd
CY2024Q2	SSSS	Investment Owned Percent Of Investment Portfolio InvestmentOwnedPercentOfInvestmentPortfolio	1.000	pure
CY2024Q2	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1.127	pure
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	184081249	usd
CY2023Q4	SSSS	Investment Owned Percent Of Investment Portfolio InvestmentOwnedPercentOfInvestmentPortfolio	1.000	pure
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.906	pure
CY2024Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	182904880	usd
CY2024Q2	SSSS	Investment Owned Percent Of Investment Portfolio InvestmentOwnedPercentOfInvestmentPortfolio	1.000	pure
CY2024Q2	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1.127	pure
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	184081249	usd
CY2023Q4	SSSS	Investment Owned Percent Of Investment Portfolio InvestmentOwnedPercentOfInvestmentPortfolio	1.000	pure
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.906	pure
CY2024Q2	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	182904880	usd
CY2023Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	247892104	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	168568251	usd
	SSSS	Transfers Transfers	-935391	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	35073044	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-10233019	usd
	SSSS	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Exercises And Conversions FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisExercisesAndConversions	44054	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-6745	usd
	SSSS	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain And Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainAndLoss	-21349177	usd
CY2024Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	171161017	usd
	SSSS	Fair Value Asset Recurring Basis Still Held Unrealized Gain And Loss Oci FairValueAssetRecurringBasisStillHeldUnrealizedGainAndLossOci	-22652903	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	143865093	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	143865093	usd
CY2023	SSSS	Transfers Transfers	-2711842	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	24485430	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-1374302	usd
CY2023	SSSS	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Exercises And Conversions FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisExercisesAndConversions	30820	usd
CY2023	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-9815023	usd
CY2023	SSSS	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain And Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainAndLoss	14088075	usd
CY2023	SSSS	Transfers Transfers	-2711842	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	168568251	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	168568251	usd
CY2023	SSSS	Fair Value Asset Recurring Basis Still Held Unrealized Gain And Loss Oci FairValueAssetRecurringBasisStillHeldUnrealizedGainAndLossOci	3136307	usd
CY2023	SSSS	Fair Value Asset Recurring Basis Still Held Unrealized Gain And Loss Oci FairValueAssetRecurringBasisStillHeldUnrealizedGainAndLossOci	3136307	usd
CY2023Q3	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	60000000.0	usd
CY2024Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2023Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2024Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10651183	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-15620024	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-32716529	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11003515	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23410235	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25952447	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24401863	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27158786	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2024Q2	SSSS	Income Loss From Continuing Operations Diluted IncomeLossFromContinuingOperationsDiluted	-10651183	usd
CY2023Q2	SSSS	Income Loss From Continuing Operations Diluted IncomeLossFromContinuingOperationsDiluted	-15620024	usd
	SSSS	Income Loss From Continuing Operations Diluted IncomeLossFromContinuingOperationsDiluted	-32716529	usd
	SSSS	Income Loss From Continuing Operations Diluted IncomeLossFromContinuingOperationsDiluted	-11003515	usd
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23410235	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25952447	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24401863	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27158786	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.34
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	33025	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	112485	usd
CY2024Q2	us-gaap	Security Deposit SecurityDeposit	16574	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	16574	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	53684	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	50441	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	106346	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	99164	usd
CY2024Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P0Y2M12D
CY2024Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0300	pure
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	33148	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	33148	usd
CY2024Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	7.17
CY2023Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	7.59
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	7.99
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	7.39
CY2024Q2	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.16
CY2023Q2	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.15
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.28
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.30
CY2023Q2	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	-0.51
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	-0.02
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	-0.48
CY2024Q2	SSSS	Investment Company Unrealized Investment Income Loss From Operations Per Share InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare	-0.30
CY2023Q2	SSSS	Investment Company Unrealized Investment Income Loss From Operations Per Share InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare	0.06
	SSSS	Investment Company Unrealized Investment Income Loss From Operations Per Share InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare	-1.04
	SSSS	Investment Company Unrealized Investment Income Loss From Operations Per Share InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare	0.37
CY2024Q2	SSSS	Investment Company Repurchase Per Share InvestmentCompanyRepurchasePerShare	0.20
CY2023Q2	SSSS	Investment Company Repurchase Per Share InvestmentCompanyRepurchasePerShare	0.33
	SSSS	Investment Company Repurchase Per Share InvestmentCompanyRepurchasePerShare	0.23
	SSSS	Investment Company Repurchase Per Share InvestmentCompanyRepurchasePerShare	0.33
CY2024Q2	SSSS	Investment Company Share Based Compensation Arrangement By Share Based Payment InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment	0.03
CY2023Q2	SSSS	Investment Company Share Based Compensation Arrangement By Share Based Payment InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment	0.03
	SSSS	Investment Company Share Based Compensation Arrangement By Share Based Payment InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment	0.06
	SSSS	Investment Company Share Based Compensation Arrangement By Share Based Payment InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment	0.04
CY2024Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	6.94
CY2023Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	7.35
CY2024Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	6.94
CY2023Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	7.35
CY2024Q2	SSSS	Market Value Value Per Share MarketValueValuePerShare	4.01
CY2023Q2	SSSS	Market Value Value Per Share MarketValueValuePerShare	3.20
CY2024Q2	SSSS	Market Value Value Per Share MarketValueValuePerShare	4.01
CY2023Q2	SSSS	Market Value Value Per Share MarketValueValuePerShare	3.20
CY2024Q2	SSSS	Investment Company Total Return Basedon Market Value InvestmentCompanyTotalReturnBasedonMarketValue	-0.1187	pure
CY2023Q2	SSSS	Investment Company Total Return Basedon Market Value InvestmentCompanyTotalReturnBasedonMarketValue	-0.1160	pure
	SSSS	Investment Company Total Return Basedon Market Value InvestmentCompanyTotalReturnBasedonMarketValue	0.0178	pure
	SSSS	Investment Company Total Return Basedon Market Value InvestmentCompanyTotalReturnBasedonMarketValue	-0.1579	pure
CY2024Q2	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.0321	pure
CY2023Q2	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.0316	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.1314	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.0054	pure
CY2024Q2	us-gaap	Shares Outstanding SharesOutstanding	23378002	shares
CY2023Q2	us-gaap	Shares Outstanding SharesOutstanding	25398640	shares
CY2024Q2	us-gaap	Shares Outstanding SharesOutstanding	23378002	shares
CY2023Q2	us-gaap	Shares Outstanding SharesOutstanding	25398640	shares
CY2024Q2	us-gaap	Assets Net AssetsNet	162312191	usd
CY2023Q2	us-gaap	Assets Net AssetsNet	186692724	usd
CY2024Q2	us-gaap	Assets Net AssetsNet	162312191	usd
CY2023Q2	us-gaap	Assets Net AssetsNet	186692724	usd
CY2024Q2	SSSS	Average Net Asset AverageNetAsset	175240305	usd
CY2023Q2	SSSS	Average Net Asset AverageNetAsset	205097855	usd
	SSSS	Average Net Asset AverageNetAsset	188879950	usd
	SSSS	Average Net Asset AverageNetAsset	207210870	usd
CY2024Q2	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.1075	pure
CY2023Q2	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.1013	pure
	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.1004	pure
	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.1041	pure
CY2024Q2	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	-0.0839	pure
CY2023Q2	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	-0.0744	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	-0.0732	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	-0.0781	pure
CY2024Q2	SSSS	Investment Company Turnover Ratio After Incentive Allocation InvestmentCompanyTurnoverRatioAfterIncentiveAllocation	0.0572	pure
CY2023Q2	SSSS	Investment Company Turnover Ratio After Incentive Allocation InvestmentCompanyTurnoverRatioAfterIncentiveAllocation	0.0209	pure
	SSSS	Investment Company Turnover Ratio After Incentive Allocation InvestmentCompanyTurnoverRatioAfterIncentiveAllocation	0.0584	pure
	SSSS	Investment Company Turnover Ratio After Incentive Allocation InvestmentCompanyTurnoverRatioAfterIncentiveAllocation	0.0389	pure
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.04	pure
	cef	Long Term Debt Principal LongTermDebtPrincipal	70000000.0	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
ssss-20240630_pre.xml	Edgar Link	unprocessable
0001493152-24-030665-index-headers.html	Edgar Link	pending
0001493152-24-030665-index.html	Edgar Link	pending
0001493152-24-030665.txt	Edgar Link	pending
0001493152-24-030665-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssss-20240630.xsd	Edgar Link	pending
ssss-20240630_cal.xml	Edgar Link	unprocessable
ssss-20240630_def.xml	Edgar Link	unprocessable
ssss-20240630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SSSS
SURO CAPITAL CORP. Stock $ssss

2024 Q3 Form 10-Q Financial Statement

#000149315224030665 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSSS SURO CAPITAL CORP. Stock $ssss

2024 Q3 Form 10-Q Financial Statement

#000149315224030665 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSSS
SURO CAPITAL CORP. Stock $ssss